Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

AIDS Drug Assistance Programs (ADAPs)

2001

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Overview

  • During the calendar year 2001, there were 54 State and U.S. Territory ADAPs operating, including the District of Columbia, Puerto Rico, Guam and the Virgin Islands.

  • Of these 54 State ADAPs, 52 submitted reports. Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. In addition, Georgia, North Carolina, and Guam did not report drug data in 2001.


New Clients and Continuing Clients, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Race/Ethnicity data are unknown for 3,573 ADAP clients in 2001.
** Other includes American Indians, Alaska Natives, people of other races, and persons of two or more races. It should be noted that the category “other races” was expanded in 2000 to include two or more races.
*** Reports on the number of Hispanics served were found to have been inflated in previous report years making these data unreliable.


Distribution of Gender, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Gender data are unknown for 63 ADAP clients in 2001.

Advertisement

Distribution of Race/Ethnicity, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Race/Ethnicity data are unknown for 3,573 ADAP clients in 2001.
** Other includes American Indians, Alaska Natives, people of other races, and persons of two or more races. It should be noted that the category “other races” was expanded in 2000 to include two or more races.
*** Reports on the number of Hispanics served were found to have been inflated in previous report years making these data unreliable.


Distribution of Age, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Age data are unknown for 79 ADAP clients in 2001.


Percent Reported Ryan White CARE Act Funding vs. Non-CARE Act Funding, 1998-2001
* Funding is as reported by grantees in the Annual Administrative Report and may not reflect actual Care Act funding.
** CARE Act funding includes Ryan White CARE Act Title I, Title II base, Title II ADAP earmark, and other Ryan White CARE Act funding. Other funding includes Medicaid, Medicare, Federal Section 329, 330, 340, other Federal, State and Local funding, other public payments, manufacturer rebates, private contributions, and client payments.
Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Percentage Distribution of Expenditures, 2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.
**Other expenditures includes ADAP funds used for administration and ancillary devices (e.g., tubing, nebulizers, etc.) needed to administer these therapies, adherence, access, and monitoring policy.


Percentage Distribution of Drugs and Other Expenditures, 1997-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.
**Other expenditures includes ADAP funds used for administration and ancillary devices (e.g., tubing, nebulizers, etc.) needed to administer these therapies.


Total Drug Expenditures by Drug Classification, 2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001. Note: See appendix for list of drugs in each drug class.


Top Ten Medications Prescribed in 2001 by the Number of Clients
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Top Ten Medications Prescribed in 2001 by Expenditures
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Appendix: List of FDA-Approved Antiretroviral Medications by Drug Class, 2001


Appendix: List of FDA-Approved Opportunistic Infection (OI) Drugs, 2001
** No State ADAPs purchased this drug.
Ganciclovir is available as a PO, implant, or IV. Pentamidine is available aerosolized.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

 
See Also
2012 National ADAP Monitoring Project Annual Report: Module One (PDF)
After Five Years, ADAP Waiting Lists Have Been Eliminated; Unmet Need and Funding Uncertainties Require Continued Commitment
More on ADAP Funding and Activism

Tools
 

Advertisement